Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

HIK Hikma Pharmaceuticals Plc

1,934.00
-20.00 (-1.02%)
13 Dec 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Hikma Pharmaceuticals Plc LSE:HIK London Stock Exchange Ordinary Share GB00B0LCW083 ORD SHS 10P
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time   RN  NRN 
   -20.00 -1.02 1,934.00 1,925.00 1,926.00 1,956.00 1,919.00 1955 145,039 16:35:28   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 2.88B 192M 0.8653 22.25 4.34B
 Type  Size  Price  Time  Units 
  12 1,934.00 16:35:29 GBX
 
Recent News
DateTimeSource
HeadlineMore HIK News
07/11/202415:30LSEG_RNSHikma Pharmaceuticals Plc Outcome of Audit Tender Process
07/11/202410:59ALNCHikma Pharmaceuticals reiterates full-year guidance amid strong growth
07/11/202410:59ALNCHikma Pharmaceuticals reiterates full-year guidance amid strong growth
07/11/202407:00LSEG_RNSHikma Pharmaceuticals Plc Trading Statement
24/10/202406:00LSEG_RNSHikma Pharmaceuticals Plc 2024 Annual General Meeting Update Statement
01/10/202408:45LSEG_RNSHikma Pharmaceuticals Plc Block listing Interim Review
24/09/202409:09LSEG_RNSHikma Pharmaceuticals Plc Director/PDMR Shareholding
Period
Draw mode
Latest Message Board Discussions
DateTimeSource
Title
Posts
07/11/202411:55PBBHikma Pharmaceuticals1,783
13/01/201515:12PBB *** Hikma ***99
Data Downloads for HIK

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)
Technical Analysis for Hikma Pharmaceuticals Plc
Get quick technical analysis for Hikma Pharmaceuticals Plc.
Price Indicators
Evaluate in real-time the trend for this stock with base on twelve different studies.
Candlesticks
Verify the trend for the closing and opening times for this stock or defined reversal patterns.
Support & Resistance
Automatically plot the main lines for support and resistance for this tock highlighting the main levels.

Latest Hikma Pharmaceuticals Plc Articles